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Nanog, Oct4, and Sox2 are the core regulators of
mouse (m)ESC pluripotency. Although their basic
importance in human (h)ESCs has been demon-
strated, the mechanistic functions are not well
defined. Here, we identify general and cell-line-
specific requirements for NANOG, OCT4, and SOX2
in hESCs. We show that OCT4 regulates, and inter-
acts with, theBMP4 pathway to specify four develop-
mental fates. High levels of OCT4 enable self-renewal
in the absence of BMP4 but specify mesendoderm in
the presence of BMP4. Low levels of OCT4 induce
embryonic ectoderm differentiation in the absence
of BMP4 but specify extraembryonic lineages in the
presence of BMP4. NANOG represses embryonic
ectoderm differentiation but has little effect on other
lineages, whereas SOX2 and SOX3 are redundant
and repress mesendoderm differentiation. Thus,
instead of being panrepressors of differentiation,
each factor controls specific cell fates. Our study
revises the view of how self-renewal is orchestrated
in hESCs.
INTRODUCTION
mESCs rely on a complex network of transcription factors to
maintain the pluripotent state (Loh and Lim, 2011). Nanog,
Oct4, and Sox2 are the core components of this network. The
POU domain protein Oct4 (Pou5f1) specifies the inner cell
mass (ICM) during embryonic development by counteracting
differentiation into trophectoderm (TE) (Nichols et al., 1998).
Carefully balanced Oct4 levels are required for the maintenance
of the pluripotent state in vitro. Inactivation of Oct4 in mESCs
causes rapid loss of self-renewal and induction of TE differentia-
tion, whereas Oct4 overexpression triggers differentiation into
endoderm (EN) and mesoderm (ME) (Ivanova et al., 2006; Niwa
et al., 2000). The homeodomain-containing protein Nanog con-
trols the epiblast versus primitive endoderm (pEN) decision in
the blastocyst (Chazaud et al., 2006). Nanog-depleted blasto-
cysts fail to establish ESC lines and differentiate into pEN in
culture (Mitsui et al., 2003). Downregulation of Nanog in mESCs
yields a broader repertoire of cell lineages, with primary contribu-440 Cell Stem Cell 10, 440–454, April 6, 2012 ª2012 Elsevier Inc.tion to TE and pEN (Ivanova et al., 2006). The SRY-related HMG
box protein Sox2 is required for epiblast maintenance (Avilion
et al., 2003) and Sox2-depleted mESCs differentiate into TE
(Ivanova et al., 2006; Masui et al., 2007).
Per the prevailing model (Jaenisch and Young, 2008), Nanog,
Oct4, and Sox2 cooperatively maintain the regulatory net-
work responsible for self-renewal and pluripotency. Molecular
analyses in mESCs have demonstrated that Nanog, Oct4, and
Sox2 coregulate large cohorts of genes (Ivanova et al., 2006)
and co-occupy many regulatory loci (Boyer et al., 2005; Loh
et al., 2006). Cobinding of these factors at the active enhancers
recruits the global transcriptional coactivator p300 (Chen et al.,
2008), whereas cobinding at the promoters of developmental
regulators mediates gene silencing (Boyer et al., 2005).
Given the key roles of Nanog, Oct4, and Sox2 in mESCs
and their ability to induce pluripotency in human somatic cells
(Takahashi et al., 2007; Takahashi and Yamanaka, 2006; Yu
et al., 2007), it has been assumed that these genes have impor-
tant and conserved functions in hESCs. However, due to a great
discrepancy in the results reported by different groups (Table 1),
the functions of these genes in hESCs remain poorly defined.
Here, by systematically analyzing the phenotypes in knock-
down and overexpression cells, we identify three unique features
of the pluripotency network in hESCs: (1) NANOG, OCT4, and
SOX2 repress primarily embryonic rather than extraembryonic
cell fates; (2) the regulatory loop between these genes is
uncoupled, allowing the expression of SOX2 in the absence of
NANOG and OCT4, as well as expression of NANOG and
OCT4 in the absence of SOX2; and (3) instead of working as pan-
repressors of differentiation, each factor controls specific cell
fates. Our studies delineate unique regulatory circuitry that main-
tains self-renewal and controls lineage commitment in hESCs.
RESULTS
Cell-Line-Specific Usage of Pluripotency Factors
in hESCs
To assess the contributions of pluripotency factors to hESC self-
renewal, we inactivated each gene using a lentiviral short hairpin
RNA (shRNA) vector (Figure 1A). Prior to these experiments, we
confirmed that vector-transduced hESCs can be maintained
in culture for more than 20 passages, while retaining stable
mCherry expression and the ability to form teratomas (data not
shown). To ensure efficient gene downregulation, twenty
shRNAs were tested for each gene and three constructs with
5- to 10-fold reductions in RNA and protein levels were selected.
Table 1. Summary of Previous Work on NANOG, OCT4, and SOX2 in hESCs
Study Genes Analyzed hESC Lines Culture Conditions KD Method Time of Analysis Markers Observed
(Babaie et al., 2007) OCT4 H1 feeder-free; MEF-CM +
KSR + bFGF
siRNA transfection 3 days TE
(Hay et al., 2004) OCT4 H1, H9 feeder-free; MEF-CM +
KSR + bFGF
siRNA transfection 2 days pEN in H9,
but not in H1
(Matin et al., 2004) OCT4 H7, H14 MEF monolayer
KSR + bFGF
siRNA transfection 3 days TE
(Vallier et al., 2009) NANOG H9, hSF6 feeder-free;
chemically defined +
Activin A + bFGF
stable shRNA multiple
time points
NE
(Zaehres et al., 2005) OCT4, NANOG H9 MEF monolayer +
KSR + bFGF
lentiviral shRNA 3 and 7 days for OCT4: none;
for NANOG:
TE, pEN
(Hyslop et al., 2005) NANOG H1, NCL1 MEF monolayer+
KSR + bFGF
siRNA transfection 4 days TE, pEN
(Fong et al., 2008) NANOG,
OCT4, SOX2
H1, H9 MEF monolayer +
KSR + bFGF
siRNA transfection 4 days TE, pEN for
all three factors
(Adachi et al., 2010) SOX2 khES1, HES3 MEF monolayer +
KSR + bFGF
siRNA transfection 3 days TE, EN
TE, trophectoderm; pEN, primitive endoderm; NE, neuroectoderm; MEF, mouse embryonic fibroblast; MEF-CM, MEF-conditioned media; KSR,
KnockOut Serum Replacement (Sigma).
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NANOG, OCT4, and SOX2 in hESCsFunctional and molecular differences among hESC lines have
been documented (Bock et al., 2011). We considered that the
requirements for pluripotency factors may also vary. To deter-
mine which hESC lines would be the most informative, we
compared gene expression profiles of 20 hESC lines, including
H1, H7, H9, and 17 HUES hESC lines (Bock et al., 2011).
Principal component analysis (PCA) revealed that the majority
of HUES lines clustered with H7 cells, whereas H1 and H9 cells
were distant from each other and from H7 cells, defining three
potentially distinct classes of hESCs (Figure 1B). Given these
results, we analyzed H1, H7, and H9 cells.
To measure self-renewal in shRNA-transduced (KD) hESCs,
we performed a fluorescence-based competition assay (Fig-
ure 1C). mCherry-positive (mCherry+) KD hESCs were mixed
with hESCs transduced with the nontargeting GFP-expressing
vector (GFP+), and mCherry+/GFP+ ratios were measured for
six passages. As expected, the mCherry+/GFP+ ratio remained
constant in control cocultures. Rapid decreases in mCherry+/
GFP+ ratios were observed for all NANOG and OCT4 shRNAs
in all three lines (Figure 1D). However, in SOX2-KD cocultures,
the mCherry+/GFP+ ratio decreased only in H1 cells. That
NANOG and OCT4 are required for self-renewal contrasts with
SOX2, which may be dispensable in certain hESC lines.
To determine whether the loss of pluripotency factors in-
duces differentiation, we analyzed pluripotency profiles (Figures
1E–1G). Eight days after transduction, NANOG-KD H1 cells
downregulated the cell surface antigen TRA1-81 and OCT4;
however, the retention of SOX2 (Figure 1E) suggested a conver-
sion into the neuroectoderm (NE). In contrast, SOX2-KD cultures
maintained unaltered marker levels, suggesting that these cells
remain undifferentiated (Figure 1F). Similar results were obtained
for NANOG and SOX2 in all three cell lines. In contrast, the
marker profiles in OCT4-KD cells were cell line dependent (Fig-
ure 1G). OCT4-KD H1, H7, and H9 cells each downregulated
SSEA-4, TRA1-81, and NANOG; however, H9 cells retainedhigh levels of SOX2, suggesting that, similar to NANOG-KD cells,
OCT4-KD H9 cells convert into NE.
To further investigate lineage induction, factor-specific differ-
entiation signatures were identified by microarrays. The expres-
sion of 1,952 genes was perturbed more than 2-fold in at least
one experiment (Table S1 available online); this data set was
visualized by PCA (Figure 1H). As expected, SOX2-KD H1 cells
clustered with control cells, while significant changes were
observed in NANOG-KD and OCT4-KD H1 cells. Interestingly,
NANOG-KD and OCT4-KD cells diverge on the PCA plot, sug-
gesting the emergence of different cell types. OCT4-KD H9 cells
were also profiled and clustered with NANOG-KD H1 cells and
away from OCT4-KD H1 cells. Taken together, these results
suggest that the usage of pluripotency factors in hESCs differs
from mESCs and varies among hESC lines.
Cell-Line-Specific Phenotypes in OCT4-KD hESCs Are
Due to Differential Activation of the BMP4 Pathway
To determine which differentiation programs are activated in
OCT4-KD hESCs, we analyzed lineage markers in these cells.
OCT4 KD in H1 cells resulted in a complexmarker pattern. Extra-
embryonic ectoderm (exEC) markers CDX2, HAND1, GATA3,
TFAP2A, and KRT7 were upregulated. Markers expressed in
both extraembryonic and embryonic ectoderm (eEC), such as
DLX3, DLX5, and MSX1/2, were also induced (Figures 2A and
S1, available online). pEN marker SOX7, GATA6, and GATA4
were also induced, whereas primitive streak (PS) and NE
markers were not. A similar pattern was observed in OCT4-KD
H7 cells (Figures 2A, S1). Downregulation of OCT4 in H9 cells,
however, did not induce markers observed in H1 and H7 cells,
but rather the NE marker PAX6. In the presence of serum,
another NE marker, ZIC1, and the neural rosette marker PLZF
were also induced (Figures 2A, S1). Therefore, OCT4 is required
to repress both extraembryonic and epiblast-derived lineages,
and the exact differentiation programs activated by OCT4Cell Stem Cell 10, 440–454, April 6, 2012 ª2012 Elsevier Inc. 441
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Figure 1. Requirements for NANOG, OCT4, and SOX2 in hESC Self-Renewal
(A) Lentiviral vectors expressing both shRNA and Hygromycin-mCherry fusion protein were utilized in this study.
(B) PCA of gene expression in 20 hESC lines from Bock et al. (2011) identified three hESC classes. Three PCs that account for 52% of the variance in the data set
are shown.
(C) A fluorescence-based competition assay was designed to measure changes in self-renewal.
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NANOG, OCT4, and SOX2 in hESCsdownregulation are specified by additional hESC-line-specific
regulatory components.
To identify such cell-line-specific components, we compared
the microarray signatures of OCT4-KD H1 and H9 cells. We
found that BMP4, which induces exEC markers in hESCs
(Xu et al., 2002) and its downstream targets—ID1, ID2, and
SMAD6—were upregulated immediately after OCT4 KD in H1
cells, but not in H9 cells (Table S1, Figure 2A). To determine
whether BMP4 signaling is required for the induction of markers
observed in OCT4-KD H1 cells, cells were treated with the BMP4
inhibitor NOGGIN. Low concentrations of NOGGIN permitted
induction of some exECmarkers, but not pENmarkers, whereas
high concentrations of NOGGIN led to a complete switch toward
the NE. Conversely, an addition of BMP4 to the culture media
was sufficient to block NE induction in H9 cells and to induce
markers observed in H1 and H7 cells (Figure 2A).
Taken together, these findings suggest that BMP4 is a critical
cell-line-specific target of OCT4 in hESCs that drives the induc-
tion of exEC and pEN differentiation programs in OCT4-KD cells.
In the absence of BMP4 signaling, NE differentiation is activated
as a default lineage choice.
OCT4 Expression and BMP4 Signaling Combinatorially
Specify Cell Fates in hESCs
To determine whether BMP4 induction alone accounts for the
marker pattern observed in OCT4-KD H1 cells, we compared
microarray profiles of OCT4-KD and BMP4-treated H1 cells.
The 1,395 OCT4-responsive and 1,466 BMP4-responsive genes
were identified and showed significant overlap (Figure 2B,
Table S1). The overlapping gene set was enriched for gene
ontology (GO) functions associated with differentiation and
development, and contained many markers that are expressed
in both extraembryonic and PS lineages, including CDX2,
HAND1, TFAP2A, and GATA3. OCT4-responsive genes that
did not respond to BMP4 treatment were enriched for GO
functions associated with cell proliferation and metabolism and
contained exEC markers DLX3 and KRT7. In contrast, BMP4-
responsive genes that were not OCT4 responsive were enriched
for functions associated with development and differentiation,
and contained the key ME-specifying genes T, MIXL1, and
EOMES. Thus, gene expression data suggested that in hESCs,
BMP4 signaling directs ME differentiation when combined with
high levels of OCT4, but results in exEC/pEN differentiation
when combined with low levels of OCT4.
To further test this hypothesis, we monitored marker induction
in BMP4-treated andOCT4-KDH1 cells by immunofluorescence
staining. With BMP4 treatment, both CDX2 and T were induced
at day 2 when OCT4 levels remained high (Figure 2C). Costaining
with T, CDX2, and OCT4 antibodies revealed that all T+ cells
were also positive for CDX2 and OCT4 (Figures 2G and 2E).(D) The proportions of KD cells in competition cocultures weremeasured at each p
gene. RNA levels of targeted genes were quantified by qPCR and are shown as
(E–G) Protein levels of pluripotencymarkers in NANOG (E), SOX2 (F), andOCT4-K
with OCT4, NANOG, SOX2, SSEA-4, and TRA1-81 antibodies and analyzed by FA
The middle and bottom rows show expression of pluripotency markers in the ga
(H) Factor-specific differentiation signatures were identified by microarrays. RNA
used to interrogate Illumina arrays. 1,952 nonredundant genes with expression pe
Two PCs that account for 58% variability in this data set are shown.
See also Table S1.No T+ cells were found in OCT4-KD H1 cultures (Figure 2D).
By day 4, BMP4-treated cells downregulated OCT4 and T and
upregulated HAND1, which was largely expressed in CDX2Low
cells (Figures 2C, 2H, and 2E). HAND1 functions in exEC, but it
is also a marker of cardiac and lateral ME (Barnes et al., 2010),
which lacks CDX2. Therefore, the HAND1+ subset in BMP4-
treated cultures likely represents ME lineage. Thus, BMP4
signaling combined with high OCT4 levels drives ME differen-
tiation, which agrees with the recent report showing that
BMP4-treated hESCs adopt ME rather than TE fates (Bernardo
et al., 2011).
The lack of T, MIXL1, and EOMES expression in OCT4-KD
cells argues against the possibility that these cells are ME
derived. CDX2+HAND1+ cells, a phenotype unique for the
exEC in the mouse, were the most abundant cell population in
these cultures (Figures 2D, 2H, and 2E) and were accompanied
by clusters of KRT7+ cells that resembled multinucleated syncy-
tiotrophoblast (Figure 2F, top). Although a small number of
KRT7+ cells could be obtained in BMP4-treated cultures in the
presence of serum, these cells resemble mesenchymal rather
than TE-like cells (Figure 3F, bottom). However, while OCT4-
KD cultures expressed many exEC markers, EOMES and
ELF5, two genes that are required for the long-term proliferation
of trophoblast stem cells (TSCs) in the placenta (Hemberger
et al., 2010), were not induced. Furthermore, the proximal
promoter of the ELF5 gene remained hypermethylated in a large
fraction of OCT4-KD H1 cells (Figure S2A). Therefore, although
loss of OCT4 in H1 cells generates a phenotype resembling
exEC, it is insufficient for establishing TSCs from hESCs.
In addition to HAND1+ cells that accounted for nearly 90% of
OCT4-KD H1 culture, about 8% of day 4 OCT4-KD H1 cultures
also expressed pEN marker SOX7 (Se´guin et al., 2008), which
was not detected in BMP4-treated cells (Figures 2C, 2D, 2E,
and 2I). Given that exEC and pEN do not share a common
precursor, we questioned whether the observed marker pattern
reflects heterogeneity within the H1 culture, in which case, the
exEC and pEN genes would be induced in nonoverlapping
subsets of cells. Immunofluorescence staining with SOX7 and
CDX2 antibodies revealed that many SOX7 cells coexpressed
CDX2 (Figures 2I and 2E). Similarly, GATA6+ cells weakly
expressed exEC marker TFAP2A at day 6 (Figure S2B). Thus,
in hESCs, OCT4 represses both exEC and pEN genes in the
same cell.
In OCT4-KD H9 cells, PAX6+SOX2+ cells were the main cell
population, confirming the result of qPCR analyses (Figure 2J).
Given that ME differentiation is not observed in OCT4-KD
hESCs, we asked whether high levels of OCT4 are also required
for the differentiation into definitive endoderm (dEN). Inactivation
of OCT4 significantly reduced the number of SOX17+ dEN
progenitors compared to control cells (Figure S4A).assage in H1, H7, and H9 cells. Three shRNA constructs were assayed for each
a percentage of wild-type levels above each graph.
D (G) cells were assayed 8 days after shRNA transduction. Cells were costained
CS. The transduced cells were gated based on mCherry expression (top row).
ted subsets.
from KD and control cells was collected daily during an 8 day time course and
rturbed more than 2-fold in at least one experiment were used in PCA analysis.
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Figure 2. OCT4 Regulates, and Interacts with, the BMP4 Pathway to Specify Distinct Developmental Programs
(A) Cell-line-specific differentiation signatures were observed in OCT4-KD hESCs. Expression of lineage markers and BMP4 pathway components was analyzed
in H1, H7, and H9 cells. After shRNA transduction, cells were maintained in mTeSRmedia with or without cytokines. RNA samples were collected as a 9 day time
course and analyzed by qPCR. Data was normalized to GAPDH and scaled to the maximum value of 1. Marker induction levels calculated as ratios between the
maximum and minimum expression are shown next to marker names.
(B) OCT4-KD and BMP4-treated H1 cells exhibit overlapping gene expression signatures. RNA samples for each treatment were collected as an 8 day time
course and used to interrogate Illumina arrays. Genes upregulated or downregulated at least 2-fold between BMP4-treated and control time courses were
defined as BMP4 responsive. OCT4-KD data set contain genes differentially expressed between OCT4-KD and control time courses.
(C and D) Marker profiles of BMP4-treated (C) and OCT4-KD (D) hESCs suggest induction of different lineages. Cells were maintained in mTeSR media and
analyzed using the indicated primary antibodies.
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Cell Stem Cell
NANOG, OCT4, and SOX2 in hESCsTaken together, these findings suggest that OCT4 and BMP4
combinatorially define four cell fates (Figure 2K). High levels of
OCT4 permit hESC self-renewal in the absence of BMP4 but
promote ME differentiation in the presence of BMP4. Low levels
of OCT4 induce NE differentiation in the absence of BMP4 but
activate exEC and pEN genes in the presence of BMP4.
Low Levels of SOX2 Are Permissive for hESC
Self-Renewal
SOX2-KD hESCs exhibit an unaltered pluripotency profile (Fig-
ure 1). To test the long-term self-renewal of SOX2-KD hESCs,
single-cell-derived clones with very low SOX2 levels were estab-
lished (Figure 3A) and evaluated by morphology and SSEA-4
expression. Although there was an increase in differentiated
SSEA-4 cells in SOX2-KD clones, distinct SSEA-4+ popula-
tions were maintained for more than 20 passages (Figure 3B).
Microarray profiling of SSEA-4+ cells FACS-purified from
SOX2-KD clones identified no changes in the expression of plu-
ripotency markers NANOG and OCT4. However, an increase in
the expression of T, FOXA2, and EOMES was detected, sug-
gesting that hESCs with low SOX2 levels may be biased toward
the PS (Figure 3C). Indeed, under the self-renewing conditions,
8% of cells in SOX2-KD cultures express either T or FOXA2
(Figure S3A). To investigate this lineage bias further, SOX2-KD
cells were differentiated into PS derivatives. In the presence of
ACTIVIN A, which promotes dEN differentiation (Borowiak
et al., 2009), both control and SOX2-KD clones gave rise to
SOX17+ cell clusters (Figure 3D). However, SOX2-KD clones
were highly efficient in generating SOX17+ clusters in the
absence of ACTIVIN A, unlike the control clones. To test ME
potential of SOX2-KD clones, cardiomyocyte differentiation
was induced inmonolayer cultures and scored by the expression
of cardiomyocyte marker cTNT (Osafune et al., 2008). No cTNT+
cells were detected in the control cultures, while SOX2-KD
clones gave rise to multiple cTNT+ clusters (Figure 3E). Hemato-
poietic differentiation was induced by sequential treatments with
ACTIVIN A, BMP4, and VEGF, and scored by the expression of
CD34 and CD31 (Lu et al., 2008). A 5- to 10-fold increase in
CD34+ as well as CD34+CD31+ cells was observed in SOX2-
KD cultures relative to the control (Figures 3F and 3G).
Elevated PS markers and their enhanced ability to form PS
derivatives in functional assays raised a question of whether
SOX2-KD cells are operationally pluripotent or instead represent
self-renewing PS progenitors incapable of eEC differentiation.
This was examined by differentiation into neural and epidermal
progenitors in vitro. Although SOX2-KD clones did not form
PAX6+ cells (Figure S4B), their ability to form TP63+ epidermal
progenitors was unaffected (Figure 3H). Furthermore, multiline-
age teratomas consisting of tissue structures derived from three
germ layers were obtained for all SOX2 clones tested (Figure 3I).(E) Putative precursor subsets in BMP4-treated and OCT4-KD hESCs differ in O
confocal images costained with CDX2, OCT4, DAPI, and a subset-specific marke
expression values for the other three channels were extracted using ImageJ s
scatter plot.
(F) Morphologies of KRT7+ cells in OCT4-KD (top) and BMP4-treated (bottom) c
mTeSR media and BMP4-treated cells were maintained in MEF-conditioned me
(G–J) Costaining identifies putative precursor populations in BMP4-treated and O
(K) A model of lineage specification by OCT4 and BMP4.
See also Figures S1, S2, S4, and Table S1.Taken together, these data suggest that SOX2-KD hESCs
maintain pluripotency, albeit less efficiently than control cells.
SOX2 and SOX3 Are Redundant and Repress PS
Differentiation
We next tested whether SOX3, which is redundant with SOX2 in
the NE (Graham et al., 2003), is expressed in hESCs and could
compensate for the loss of SOX2. The expression of SOX3 in
hESCs was low (Figures 4A–4C) and its depletion by shRNAs
did not affect hESC morphology or the marker profile (Figures
4E, S3B, S3C). However, SOX3 was induced in SOX2-KD cells
(Figures 4A–4C). Simultaneous depletion of SOX2 and SOX3
resulted in hESC differentiation, which was most pronounced
in H1 cells (Figure 4D). Lineage analysis in SOX2/3-KD H1 cells
revealed the induction of dEN markers GATA6, GATA4,
FOXA2, and SOX17 (Figure 4F). CDX2 was also induced in the
absence of other exEC genes, as occurs in the gut (Gao et al.,
2009), and ME markers T, MIXL1, and EOMES were also
induced. By immunofluorescence staining, FOXA2+ cells were
abundant in SOX2/3-KD cultures and were negative for T, but
positive for SOX17, indicating the emergence of distinct PS
populations (Figure 4G).
These data suggest an inverse correlation between SOX2 and
SOX3 levels in hESCs. The SOX2HighSOX3Low cells maintain
a high rate of self-renewal and the potential to contribute to
both NE and PS lineages, whereas SOX2LowSOX3High cells
have a reduced capacity to self-renew, but retain pluripotency.
Downregulation of SOX3 in these cells initiates commitment
to PS (Figure 4H).
NANOG Represses NE and Neural Crest Commitment
in hESCs
Two different phenotypes in NANOG-KD hESCs have been
reported: with MEF-conditioned media and siRNAs, exEC and
pENmarkers were induced, while with chemically defined media
and stable shRNAs, a NE phenotype was observed (Table S1).
FACS profiling of NANOG-KD cells (Figure 1E) identified the
OCT4/SOX2+ phenotype compatible with NE differentiation.
However, significant proportions of NANOG-KD H1, H7, and H9
cultureswereOCT4Intermediate/SOX2+, representingeitherastage
that precedes NE or a non-NE lineage. To determine the marker
profile of NANOG-KD cells, we performed qPCR analyses of
H1, H7, andH9 cells inMEF-conditionedmedia, which is permis-
sive for a broad spectrum of lineages. While markers of ExEC,
pEN, and PS were undetected, various marker combinations of
eEC were induced in all three cell lines (Figure S1). In addition
to NE markers PAX6, ZIC1, and PLZF, NANOG-KD hESCs
induced neural crest (NC) markers GBX2 and PAX3, suggesting
that NANOG represses a broader range of eEC derivatives. H7
cells were positive for OTX2, which, in the mouse, is expressedCT4 and CDX2 levels. Protein levels in individual cells were quantified using
r. Cells with the highest levels of the subset-specific marker were selected and
oftware. Background-corrected Log2-transformed signals are displayed as a
ells suggest exEC versus ME differentiation. OCT4-KD cell were maintained in
dia for 7 days.
CT4-KD hESCs.
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Figure 3. Low SOX2 Levels Are Permissive for Self-Renewal but Facilitate PS Differentiation
(A) Single-cell-derived clones with very low SOX2 levels were generated from SOX2-KD cells. SOX2 and OCT4 levels were assayed by western blotting (top) and
immunofluorescence (bottom).
(B) The SSEA-4+ cell population is maintained in SOX2-KD clones. FACS plots of SSEA-4 expression and the proportions of SSEA-4+ and SSEA-4 cells at
passage 10 are shown.
(C) SOX2-KD clones maintain expression profiles of undifferentiated hESCs. A scatter plot of expression data from the SOX2-KD microarray experiments is
shown. Each point corresponds to the Log2-transformed expression value of one probe in SOX2-KD and control clones. The black diagonal line represents
a 1:1 expression ratio between SOX2-KD and control clones. The red lines demarcate the 2-fold expression interval.
(D–F) Enhanced dEN (D), cardiomyocyte (E), and hematopoietic (F) differentiation is observed in SOX2-KD clones. The numbers of SOX17+ cells, cTNT+ clusters,
and CD34+ cells are shown in the bar plots next to the images. The average values and standard errors shown represent data from two replicate experiments.
(G) Both hematopoietic and endothelial markers are induced in the FACS-purified CD34+ cell subset obtained from SOX2-KD clones.
(H) SOX2-KD clones form TP63+ and KRT14+ epidermal progenitors in vitro. Cells were grown in mTeSRmedia supplemented with BMP4 for 3 days, and then in
serum-containing media for 7 days.
(I) ME, dEN, and NE-derived structures are present in teratomas from SOX2-KD clones. Hematoxylin and eosin-stained tissue sections are shown.
See also Figures S1, S3, S4 and Table S1.
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NANOG, OCT4, and SOX2 in hESCsin the anterior epiblast prior to PAX6 induction (Kurokawa et al.,
2004). H1 cells, on the other hand, were negative for OTX2 but
had higher levels of GBX2, which, in addition to its role in NC
development (Li et al., 2009), is also a posterior NE marker
(Martinez-Barbera et al., 2001) (Figures 5A–5C). Thus, downregu-
lation of NANOG in different hESC lines induces NE subsets with
different anterior-posterior identities. To test whether NE and NC
can be selectively expanded from the precursors generated in
NANOG-KD cultures, H1 cells were briefly treated with different446 Cell Stem Cell 10, 440–454, April 6, 2012 ª2012 Elsevier Inc.cytokines. Treatment with NOGGIN enhanced NE signature
(Figures 5D and 5E), whereas bFGF-treated NANOG-KD cells
resembled NC cells (Figures 5D and 5G). Stimulation with
BMP4 induced exEC and pEN lineage markers in both NANOG-
KD and control cells (Figures 5D and 5H), suggesting that
BMP4 can override early stages of NE/NC commitment in
NANOG-KD cells, similar to its effect on OCT4-KD H9 cells.
To determine whether low NANOG levels alter the potential of
hESCs to contribute to PS, NANOG-KD H1 cells were tested in
A B C D
E
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Figure 4. SOX3 Supports hESC Self-Renewal in the Absence of SOX2
(A–C) SOX3 is induced in SOX2-KD hESCs. RNA levels of pluripotency markers (A) were quantified by qPCR and are shown as fold change relative to the control.
SOX2 and SOX3 protein levels were assayed by western blotting (B). Induction of SOX3 in SOX2-KD clones was confirmed by immunofluorescence staining (C).
Prior to the assays, cells were maintained in mTeSR media for 6 days. Average values and standard errors from two replicate experiments are shown.
(D) Simultaneous depletion of SOX2 and SOX3 induces hESC differentiation. Pluripotency markers were assayed by FACS. The transduced cells in control (left)
and KD (right) cultures were gated based on mCherry expression (top). The middle and bottom rows represent marker expression in the gated subsets.
(E–G) SOX2/3-KD cells differentiate into ME and dEN. Cell morphologies (E) and RNA expression of lineage markers (F) were examined. Expression is shown as
fold change relative to the control. Average values and standard errors represent two replicate transduction experiments. Distinct PS populations are present in
KD hESCs (G). Cells were replated at low density 2 days after shRNA transduction and grown in mTeSR media for 6 days.
(H) SOX2 and SOX3 levels define a putative hESC subset with a bias toward the PS.
See also Figures S3 and S4.
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NANOG, OCT4, and SOX2 in hESCsdirected differentiation assays. Neither dEN nor hematopoietic
differentiation was affected (Figures S4A, S4C). Overall, these
data suggest that in hESCs, NANOG is a specific repressor of
NE/NC cell fates.
Overexpression of NANOG, OCT4, and SOX2 Does Not
Induce hESC Differentiation
In mESCs, a number of pluripotency regulators, including Oct4
and Sox2, function as lineage specifying factors (Loh and Lim,
2011). To determine whether NANOG, OCT4, and SOX2 func-
tion as lineage specifiers in hESCs, overexpression (OE) studies
were performed in H1 cells using lentiviral vectors (Figure 6A).
Upregulation of RNA and protein was confirmed for all three
genes (Figures 6B, 6C, S5A). In agreement with the previous
report (Teo et al., 2011), NANOG-OE cells upregulated dEN
markers EOMES, FOXA2, and SOX17; however, only a fewFOXA2+SOX17+ cells were identified by immunofluorescence
(Figure S5B). OCT4 and SOX2-OE cells did not induce any
lineage markers (Figure 6D). We used microarray profiling to
assess the effect of OE on the entire transcriptome (Figure 6E).
Only very small sets of genes were perturbed in OE cells. GO
analyses identified enrichment for metabolic functions in
NANOG and SOX2-OE data sets. Genes broadly associated
with cell proliferation and development were upregulated in
SOX2-OE cells (Table S1). However, no genes specifically
associated with germ layer induction were found in these
data sets.
To test whether elevated levels of NANOG, OCT4, and SOX2
alter the ability of hESCs to contribute to specific lineages, we
differentiated OE cells into NE and PS. No changes in hemato-
poietic or cardiomyocyte differentiation were observed (data
not shown). However, OE of SOX2 reduced the number ofCell Stem Cell 10, 440–454, April 6, 2012 ª2012 Elsevier Inc. 447
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Figure 5. NANOG Represses NE and NC Commitment in hESCs
(A andB) Expression of pluripotency (A) and differentiation (B) markers in KD cells was assessed by qPCR and is shown as a fold change relative to the control (red
dotted line). Average values and standard errors are from two replicate experiments.
(C) OTX2 and PAX6 levels were examined in H1 and H7 NANOG-KD cells 12 days after transduction. For (A)–(C) cells were maintained in mTeSR media.
(D) RT-PCR analyses of cytokine-treated cells. NANOG-KD (N) and control (C) H1 cells were maintained in mTeSR media for 6 days, split, and grown in basic
neural progenitor cell media supplemented with NOGGIN, bFGF, or BMP4 for 4 additional days.
(E–H) Expression of NE and NC markers was examined by immunofluorescence.
See also Figures S1 and S4 and Table S1.
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Figure 6. Overexpression of Pluripotency Factors in hESCs Does Not Induce Differentiation
(A) Lentiviral vectors expressing both the gene of interest and the Puromycin-resistance gene were utilized in OE studies.
(B and C) RNA and protein levels were upregulated for all three factors. RNA levels were quantified by qPCR (B), and protein levels, by western blotting (C). Signal
intensities are shown as the fold change relative to the control.
(D) RNA expression of germ layer markers was measured by qPCR and is shown relative to the control. Average values and standard errors from two replicate
transduction experiments are shown.
(E) OE cells maintain expression profiles of undifferentiated hESCs. A ‘‘volcano’’ plot of expression data for each OE construct is shown. Each point corresponds
to one probe, which is displayed based on its Log2-transformed fold change value relative to the control and Log10-transformed change p value calculated for two
replicate experiments. The vertical red lines demarcate 2-fold expression interval, and the horizontal red line corresponds to a 0.05 false-positive detection rate.
The total numbers of upregulated and downregulated genes, and GO groups with statistically significant enrichment, are shown. Microarray data can be found in
Table S1. For analyses in (A)–(E), cells were grown in Puromycin-supplemented mTeSR media for 5 days. qPCR data are shown as a fold change relative to the
control. Average values and standard errors are calculated from two replicate transduction experiments.
(F) dEN differentiation is enhanced in OCT4-OE hESCs and is inhibited in SOX2-OE cells. Monolayer cultures grown in the presence of ACTIVIN A were costained
with SOX17 and DAPI. Proportions of SOX17+ cells in OE and control samples are shown in the bar graph.
(G) NE differentiation is blocked in NANOG and OCT4-OE cells and is enhanced in SOX2-OE cells. Monolayer cultures grown in the presence of GSK-3b, TGF-b,
and g-secretase inhibitors were costained with PAX6 and factor-specific antibodies. Proportions of PAX6+ cells are shown in the bar graph.
Average values and standard errors shown in (F) and (G) represent data from four replicate experiments. For each experiment, nonoverlapping images were
quantified to obtain a total of 1,000 cell counts for each OE construct. See also Figures S4 and S5 and Table S1.
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NANOG, OCT4, and SOX2 in hESCsSOX17+ dEN progenitors and enhanced NE differentiation.
Conversely, OE of OCT4 enhanced dEN and suppressed NE
differentiation (Figures 6F and 6G). NANOG OE resulted in a
complete block of NE differentiation (Figure 6G). Given the
induction of dEN markers in NANOG-OE cells (Figure 6D) and
a recent report suggesting a cell-autonomous role for NANOG
in dEN specification (Teo et al., 2011), we were surprised to
find a decrease in the number of SOX17+ cells in NANOG-OEcells (Figure 6F). However, in the gastrula-stage mouse em-
bryos, Nanog is expressed in a posterior exEC adjacent to the
PS rather than PS itself (Hart et al., 2004; Morkel et al., 2003),
suggesting that instead of being a cell-autonomous factor,
NANOGmay enhance dEN differentiation via a non-cell-autono-
mous mechanism.
Overall, both KD and OE data strongly suggest that, in hESCs,
NANOG, OCT4, and SOX2 function as differentiation repressors,Cell Stem Cell 10, 440–454, April 6, 2012 ª2012 Elsevier Inc. 449
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Figure 7. Molecular Networks Regulated by NANOG, OCT4, and SOX2 in hESCs
(A and B) Only a small subset of binding sites is utilized by each factor to directly control gene expression. Binding data from Boyer et al. was compared with
sets of genes whose expression was perturbed at least 2-fold in the KD hESCs. Highly significant overlaps between bound and differentially expressed
genes were identified in each experiment (A). Box plots of signal value distributions for gene sets defined in (A) are shown for each KD experiment (B). The 75%
(blue box) and 95% (black lines) distribution intervals are shown, and the outliers are marked in red. The median distribution values are shown as horizontal red
lines.
(C) Lineage commitment in OCT4-KD hESCs is modulated by BMP4 signaling via a coregulation of primary targets. The overlap between the OCT4-KD and
OCT4-bound data sets is shown by Venn diagram. Genes were considered differentially expressed in both cell lines if their fold change was greater than 2.0 in at
least one of the compared groups and greater than 1.8 in the other groups. These calculations result in increased group sizes compared to the numbers shown
in (B). List of coregulated direct targets and their expression profiles in KD time courses are shown in Figure S6.
(D) Gene clusters coregulated by different combinations of pluripotency factors were identified in the microarray data set. Overlaps were calculated as described
in (C) and are shown as a Venn diagram. The expression profiles of coregulated targets are shown in Figure S7.
(E) Transcription factors repressed by NANOG, OCT4, and SOX2 induce rapid hESC differentiation when overexpressed individually in H1 cells. Transduced cells
were replated at a low density and grown in mTeSR media supplemented with Puromycin for 6 days. No morphology changes were observed in TFAP2C, ISL1,
HOXB5, and HESX1 OE cultures.
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NANOG, OCT4, and SOX2 in hESCsand that the positive signals that initiate differentiation are medi-
ated via alternative regulatory pathways.
NANOG-OCT4-SOX2-Regulated Molecular Networks
in hESCs
To analyze the molecular networks regulated by NANOG, OCT4,
and SOX2 in hESCs, we compared our data set of genes differ-
entially expressed during NANOG, OCT4, and SOX2-KD differ-
entiation (Figure 1H) with the data set of genes bound by
NANOG, OCT4, and SOX2 (Boyer et al., 2005). To estimate the
fraction of all binding sites that are functional in hESCs, we
identified the genes bound by each factor and differentially ex-
pressed in the knockdown experiments (Figure 7A). More than
80% of all OCT4-bound genes represented on the microarray
did not show a measurable change in expression in OCT4-KD
hESCs; the majority of these genes were expressed at low levels
in both H1 andH9 cells. Similar results were obtained for NANOG
and SOX2 (Figures 7A and 7B). Furthermore, for each regulator,
the direct targets represented only aminor fraction of all differen-
tially expressed genes. For OCT4, only 5% of genes were direct
targets, whereas indirect targets accounted for more than 94%
of OCT4-KD differentially expressed genes (Figure 7A). For
each of three factors, the direct targets were enriched for GO
functions associated with transcriptional control and regulation
of differentiation, while the indirect targets were enriched for
a broader range of cellular functions, including differentiation
and tissue development, signaling, cell division, cell migra-
tion, cytoskeleton organization, and regulation of apoptosis
(Table S1). Thus, in hESCs, NANOG, OCT4, and SOX2 directly
repress or activate small sets of downstream transcriptional
regulators, which in turn control a broader range of cellular
processes.
Because OCT4 KD induces nonoverlapping phenotypes in H1
andH9 cells (Figure 2), we next identified transcriptional changes
that accompany lineage induction in these two cell lines. In at
least one cell line, 1,577 geneswere differentially expressed (Fig-
ure 7C). Among the direct OCT4 targets, 40 genes were coregu-
lated in both H1 and H9 cells, whereas 42 genes were specific in
H1 cells and 9 genes were specific for H9 cells (Figures 7C, S6),
suggesting that lineage commitment in OCT4-KD hESCs is
modulated by external signals, such as BMP4, via a coregulation
of primary targets.
In mESCs, Nanog, Oct4, and Sox2 coregulate large cohorts of
downstream genes (Ivanova et al., 2006). Surprisingly, a different
pattern of target regulation was observed in hESCs. We found
that a small group of only 111 genes requires all three factors
for the maintenance of proper expression, whereas a larger set
of 252 genes is coregulated by NANOG and OCT4, and another
set of 158 genes is coregulated by OCT4 and SOX2 (Figures
7D, S7). GO analyses revealed an enrichment of gene-products
involved in differentiation and development in all three gene sets.
Large regulator-specific gene clusters were also identified. The
OCT4 cluster was uniquely enriched for GO functions associated
with vascular development, regulation of the cell cycle, and(F) Microarray profiles of 14 regulators of differentiation in 8 day differentiation time
maps. No binding was observed for TFAP2A, MSX1, MSX2, and SOX7. Microar
deviation 1 and are displayed as heat maps with low expression shown in green
(G) Model of cell fate regulation by NANOG, OCT4, and SOX2/3 in hESCs. See acell adhesion. The NANOG cluster was enriched for genes asso-
ciated with neurogenesis and brain development, while the
SOX2 cluster was enriched for genes associated with tissue
morphogenesis (Table S1).
To define critical differentiation-promoting genes repressed
by NANOG, OCT4, and SOX2, we analyzed 18 transcription
factors that were induced immediately after the depletion of plu-
ripotency genes (Figure 7E) for their ability to induce hESC differ-
entiation. OE of these genes was performed using lentiviral
vectors (Figure 6A). In 14 cases, rapid hESC differentiation was
indicated by morphology changes in the cultures (Figure 7E).
The majority of these differentiation genes are coregulated by
NANOG and OCT4 with an additional input from the BMP4
pathway (Figure 7F).
Taken together, these data suggest a modular pluripotency
network in hESCs. Instead of working as a trio, NANOG, OCT4,
and SOX2 are recruited into smaller regulatory modules that
contribute to themaintenance of self-renewal and the repression
of lineage-specific differentiation.
DISCUSSION
In this study, we asked how NANOG, OCT4, and SOX2 maintain
hESC pluripotency. Using loss- and gain-of-function assays
coupled with transcriptome profiling, we identified requirements
for NANOG, OCT4, and SOX2 in hESCs. In mESCs, all three
factors are required for self-renewal, and their inactivation
results in exEC/pEN differentiation with little, if any, effect on
the epiblast-derived cell fates, which are separately repressed
by the Esrrb-Tbx3-Tcl1 regulatory module (Ivanova et al., 2006).
We find that the general requirements for NANOG, OCT4, and
SOX2 are different between mouse and human ESCs. In hESCs,
OCT4 controls both extraembryonic and epiblast-derived cell
fates that are chosen in a BMP4-dependent manner. High levels
of OCT4 permit hESC self-renewal in the absence of BMP4 and
promote PS differentiation in the presence of BMP4. Low OCT4
levels induce NE differentiation in the absence of BMP4 and
specify exEC/pEN lineages in the presence of BMP4.
We show that NANOG represses NE/NC differentiation.
Furthermore, the outcomes of functional assays suggest that
NANOG contributes minimally, if at all, to the repression of
other lineages. Thus, instead of being a general repressor
of differentiation, NANOG has a lineage-restricted function in
hESCs.
In contrast to OCT4 and NANOG, which are required for
hESC self-renewal, SOX2 is largely dispensable due to compen-
sation by SOX3. SOX3 expression is low in hESCs, but is upregu-
lated upon SOX2 depletion, permitting hESC self-renewal.
SOX2LowSOX3High cells remain pluripotent, but exhibit enhanced
spontaneous differentiation toward the PS fates. Simultaneous
depletion of both SOX2 andSOX3 results in a loss of self-renewal
and ME/dEN differentiation.
Another conclusion from our study is that the usage of pluripo-
tency factors varies significantly among different hESC lines. H1courses. The binding of pluripotency factors is shown in the box below the heat
ray data for each gene were normalized to the average value 0 and standard
and high expression shown in red.
lso Figures S6 and S7 and Table S1.
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NANOG, OCT4, and SOX2 in hESCsand H7 cells require OCT4 to repress BMP4 expression,
whereas an OCT4-independent mechanism operates in H9 cells.
H1 cells are more sensitive to SOX2/3 inactivation than H7 and
H9 cells. Furthermore, a line-to-line variability in eEC patterns
in NANOG-KD hESCs suggests formation of NE subsets with
different anterior-posterior identities. Because no such variability
has been reported for mESCs, we propose that in contrast to Lif/
Stat3 and Bmp4/Smad1 pathways that support a unique ICM-
specific state, a broader range of developmental states, repre-
sented by individual hESC lines, are supported by FGF2/MAPK
and TGFb/SMAD2/3 signaling. The ability of H1 and H7 cells to
induce BMP4 and other exEC markers in response to OCT4
KD suggests that these hESC lines represent an early develop-
mental state that retains a limited capacity to activate extraem-
bryonic differentiation programs. In the mouse, Bmp4 expres-
sion is detected in both ICM and polar TE and later is excluded
from the epiblast (Coucouvanis and Martin, 1999). In contrast,
Oct4 is upregulated to its maximum level in the late epiblast
(Han et al., 2010), suggesting that OCT4 may directly repress
Bmp4 during the ICM-to epiblast transition. OCT4 binding at
the BMP4 locus in hESCs (Figures S2C, S2D) supports this
model. In contrast toH1 andH7 cells, H9 cells have lost the ability
to regulate endogenous BMP4 via OCT4 and have microarray
profiles resembling the initial stages of NE differentiation, a
phenotype replicated in NANOG-KD hESCs (Figure 1H), sug-
gesting that these cells may represent later epiblast. Further-
more, SOX2LowSOX3High cells generated following SOX2 KD
likely represent the posterior epiblast. During gastrulation,
Sox2 becomes restricted to the anterior half of the embryo while
Sox3 is upregulated throughout the eEC (Wood and Episkopou,
1999). High Sox3 expression in epiblast cells adjacent to the PS
is needed to antagonize the expression of the transcriptional
repressor Snail, prevent ingression into the PS territory, and
ensure the formation of posterior eEC derivatives (Acloque
et al., 2011).
Per the prevailing model, NANOG, OCT4, and SOX2 work as
a trio to support each others’ expression and that of other self-
renewal genes, and to repress differentiation genes (Boyer
et al., 2005). Although functional and molecular analyses in
mESCs agree with that model (Ivanova et al., 2006), our study
identifies differences in the organization and function of the
pluripotency network in hESCs. While NANOG and OCT4 are
coregulated in all three hESC lines (Figures 1E–1G, 2B), SOX2
is excluded from the loop. Indeed, downregulation of either
NANOG or OCT4 in the absence of BMP4 signaling does not
affect SOX2 expression and both NANOG and OCT4 levels are
unchanged in SOX2-KD cells. Furthermore, a small group of
only 111 genes requires all three factors for the maintenance of
proper expression, whereas larger groups of genes are regulated
by NANOG-OCT4 and OCT4-SOX2 pairs, and by individual
factors. Thus, instead of working as panrepressors of differen-
tiation, the pluripotency factors individually repress specific
cell fates.
In addition to providing new insights into the regulation of
pluripotency, our findings are important for lineage commitment
studies in hESCs. The lineage of cells in BMP4-treated hESC
cultures has been a longstanding paradox in the field, with the
most recent report (Bernardo et al., 2011) suggesting that these
cells are of ME, rather than TE, origin as initially proposed452 Cell Stem Cell 10, 440–454, April 6, 2012 ª2012 Elsevier Inc.(Xu et al., 2002). We show that BMP4 drives differentiation of
both ME and TE, but the exact cell type is specified by the levels
of OCT4. Low levels of OCT4 mimic the TE phenotype, but are
insufficient to specify TSCs. ELF5, a factor required for the
TSC maintenance in human placenta (Hemberger et al., 2010),
is not induced and its promoter remains hypermethylated in
OCT4-KD hESCs (Figure S2A). This contrasts with mESCs,
where downregulation of Oct4 leads to the establishment of
functional TSCs that are able to colonize exEC in chimeras
(Niwa et al., 2005). There are three possible explanation why
this could be the case. First, the similarity between hESCs and
the mouse epiblast suggests that hESCs may have passed the
developmental window when functional TSCs can be estab-
lished. Second, the signaling in hESC culturesmay be incompat-
ible with TSC differentiation/maintenance. Third, human TSCs
may be specified later in development. The latter hypothesis is
supported by the recent finding that, in the cattle, ELF5 is not
expressed in TE at the blastocyct stage. Furthermore, a cattle
ELF5 BAC reporter is not expressed in mouse TE, even though
it is expressed in embryonic skin, another domain of ELF5
expression (Pearton et al., 2011).
In mESCs, multiple transcription factors are required for the
maintenance of the pluripotent state (Loh and Lim, 2011).
Likewise, additional factors are likely to be required in hESCs;
several candidate genes have already been identified (Adamo
et al., 2011; Chia et al., 2010; Zhang et al., 2011). It will be
important to investigate how these novel regulators control
pluripotency and how they are integrated with the NANOG-
OCT4-SOX2 network described here.
EXPERIMENTAL PROCEDURES
Cell Culture and Differentiation Assays
hESC lines H1, H7, and H9were obtained from the YSCC hESCCore under the
appropriate MTAs and were maintained as originally described (Thomson
et al., 1998). BMP4 induction was performed in mTeSR media. dEN, cardio-
myocyte, hematopoietic, and NE differentiation was carried out as previously
described (Borowiak et al., 2009; Li et al., 2011; Lu et al., 2008; Osafune et al.,
2008).
shRNA Design
shRNAs were designed and cloned as described in Ivanova et al. (2006). The
list of shRNAs utilized in this study is available in the Supplemental Information.
Quantitative PCR
Total RNA was reverse transcribed using Superscript II and random primers.
qPCR was carried out using iQ SYBR Green Supermix (Bio-Rad). Gene-
specific primers utilized in this study are available in the Supplemental
Information.
Immunoblotting, Immunofluorescence, and Flow Cytometry
Whole-cell protein extracts were prepared using RIPA buffer. Immunofluores-
cence staining was performed on paraformaldehyde-fixed cells. For the FACS
analyses, single-cell suspension was prepared using Accutase. The list of anti-
bodies and dilution ratios are available in the Supplemental Information.
Gene Expression Microarrays, GO, and PCA
Microarrays were conducted on HumanHT-12 v4 Expression BeadChip
arrays. Data was normalized using the cubic spline normalization algorithm
in the BeadStudio (Illumina). Differentially expressed genes were identified
using Log2FC > 1 or < 1 and adjusted with p < 0.05. Cluster 3.0 and Java
Treeview were used for data visualization. GO was performed using DAVID
6.7 (Huang et al., 2009), and PCA, using MatLab R2010b (MathWorks).
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Microarray data are available in the Gene Expression Omnibus (GEO)
database (http://www.ncbi.nlm.nih.gov/geo/) under the accession number
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